Skip to main content

RHUMBLINE ADVISERS

Position in HROW — Harrow, Inc.

CIK 1115418 BOSTON, MA

Position in HROW

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,739,783
+$428,464 QoQ
Shares Held
40,965
+10.2% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 223 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 21% Shared 0% None 79%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. HROW ranks #24 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HROW

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,739,783 40,965
2026-03-31 $1,311,319 37,190
2025-12-31 $1,837,745 37,505
2025-09-30 $2,206,306 45,793
2025-06-30 $1,434,433 46,969
2025-03-31 $1,143,135 42,975
2024-12-31 $1,345,220 40,096
2024-09-30 $1,844,573 41,027
2024-06-30 $898,708 43,021
2024-03-31 $526,130 39,768
2023-12-31 $431,076 38,489
2023-09-30 $587,244 40,866
2023-06-30 $638,963 33,559
2021-03-31 $108,870 16,129
2020-12-31 $114,692 16,719
2020-09-30 $84,291 15,079
2020-06-30 $98,724 18,949